Column Group IV-A, LP, 10% Owner, Director at NGM BIOPHARMACEUTICALS INC (NGM), bought 278,296 shares at $4.99 ($1.4M) on 2022-11-03, disclosed to the SEC on 2022-11-07.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Clearly above the average filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $4.99 | 104,090 | $519K | 37.9% |
| 2 | $4.99 | 104,090 | $519K | 37.9% |
| 3 | $4.72 | 35,058 | $165K | 12.1% |
| 4 | $4.72 | 35,058 | $165K | 12.1% |
| Total | $4.92 avg | 278,296 | $1.4M | 100% |
| Filing → |
| RAPT | BUY | 2022-05-12 | $26.7M | — | Filing → |